Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells

Liver fibrosis is a consequence of chronic liver disease, causing morbidity and mortality. Interleukin-33 (IL-33) is a critical mediator of inflammation, which may be involved in the development of liver fibrosis. Here, we investigated the role of IL-33 in human patients and experimental bile-duct l...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Mol Immunol
Autors principals: Tan, Zhongming, Liu, Qianghui, Jiang, Runqiu, Lv, Long, Shoto, Siamak S, Maillet, Isabelle, Quesniaux, Valerie, Tang, Junwei, Zhang, Wenjie, Sun, Beicheng, Ryffel, Bernhard
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6052839/
https://ncbi.nlm.nih.gov/pubmed/28194023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cmi.2016.63
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars